EP Patent

EP3389692A1 — Modulators of complement activity

Assigned to UCB Inc · Expires 2018-10-24 · 8y expired

What this patent protects

The present invention relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics.

USPTO Abstract

The present invention relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics.

Drugs covered by this patent

Patent Metadata

Patent number
EP3389692A1
Jurisdiction
EP
Classification
—
Expires
2018-10-24
Drug substance claim
No
Drug product claim
No
Assignee
UCB Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.